SYNLAB Bondco Plc ("SYNLAB") today announced that it will launch a financing transaction aiming to raise up to a total aggregate principal amount of EUR300,000,000 through a term loan facility, maturing 2022 (the "Term Loan").
This regulatory release contains information about a pending transaction and there can be no assurance that this transaction will be completed.
Use of Proceeds
SYNLAB intends to use the proceeds of the Term Loan (i) for general corporate purposes, including, without limitation, to finance acquisitions in furtherance of its strategy of pursuing growth opportunities through selective acquisitions in its current markets and in new markets or for any capital expenditure, the servicing of any of its outstanding indebtedness or as cash on balance sheet; and (ii) to pay associated fees and expenses in connection with the funding of the transaction fees and expenses.
This notice is being provided in accordance with Regulation (EU) No 596/2014 of 16 April 2014 on Market Abuse.
For more information:
SYNLAB
Daniel Herbert, FTI Consulting
|
+ 49 (0)69 92037-183
daniel.herbert@fticonsulting.com
|